MCM
HZNP

MAI Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

MAI Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,124
Closed -$593K – 1161
2023
Q3 		$593K Sell
5,124
-8
-0.2% -$860 0.01% 581
2023
Q2 		$528K Sell
5,132
-10
-0.2% -$1.05K 0.01% 617
2023
Q1 		$561K Sell
5,142
-264
-5% -$29.2K 0.01% 598
2022
Q4 		$615K Sell
5,406
-454
-8% -$37.7K 0.01% 555
2022
Q3 		$363K Sell
5,860
-13,228
-69% -$924K 0.01% 649
2022
Q2 		$1.52M Sell
19,088
-1,826
-9% -$173K 0.03% 306
2022
Q1 		$2.2M Sell
20,914
-1,064
-5% -$104K 0.04% 253
2021
Q4 		$2.37M Buy
21,978
+7
+0% +$764 0.04% 250
2021
Q3 		$2.41M Hold
21,971
– – 0.05% 210
2021
Q2 		$2.06M Hold
21,971
– – 0.04% 229
2021
Q1 		$2.02M Hold
21,971
– – 0.05% 212
2020
Q4 		$1.61M Sell
21,971
-654
-3% -$48.6K 0.04% 233
2020
Q3 		$1.76M Buy
22,625
+2,885
+15% +$199K 0.05% 190
2020
Q2 		$1.1M Buy
+19,740
New +$845K 0.03% 260

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

MAI Capital Management's HZNP Position: Q4 2023 in Review

MAI Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 5,124 shares — an estimated $593K sold.

MAI Capital Management first reported a position in HZNP in Q2 2020 and held it in 14 quarters. The position peaked at $2.41M in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • MAI Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • MAI Capital Management sold 5,124 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $593K.
  • MAI Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2020 and held it in 14 quarters.
  • MAI Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.41M in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on MAI Capital Management's 13F filing for Q4 2023, filed 9 Feb 2024.